311 related articles for article (PubMed ID: 11972592)
1. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
Leurs R; Church MK; Taglialatela M
Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the cardiac safety of second-generation antihistamines.
Taglialatela M; Annunziato L
Allergy; 2000; 55 Suppl 60():22-30. PubMed ID: 10887972
[No Abstract] [Full Text] [Related]
3. Assessing the cardiac safety of ebastine. Epilogue.
Roberts DJ
Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
[No Abstract] [Full Text] [Related]
4. Inhibition of depolarization-induced [3H]noradrenaline release from SH-SY5Y human neuroblastoma cells by some second-generation H(1) receptor antagonists through blockade of store-operated Ca(2+) channels (SOCs).
Taglialatela M; Secondo A; Fresi A; Rosati B; Pannaccione A; Castaldo P; Giorgio G; Wanke E; Annunziato L
Biochem Pharmacol; 2001 Nov; 62(9):1229-38. PubMed ID: 11705456
[TBL] [Abstract][Full Text] [Related]
5. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.
Taglialatela M; Castaldo P; Pannaccione A; Giorgio G; Genovese A; Marone G; Annunziato L
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():182-9. PubMed ID: 10444235
[TBL] [Abstract][Full Text] [Related]
6. Of oocytes and runny noses.
Rosen MR
Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
[No Abstract] [Full Text] [Related]
7. Inhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastine.
Taglialatela M; Pannaccione A; Castaldo P; Giorgio G; Annunziato L
Br J Pharmacol; 2000 Nov; 131(6):1081-8. PubMed ID: 11082114
[TBL] [Abstract][Full Text] [Related]
8. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
9. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
[TBL] [Abstract][Full Text] [Related]
10. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
Suessbrich H; Waldegger S; Lang F; Busch AE
FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular profile of loratadine.
Hey JA; Affrime M; Cobert B; Kreutner W; Cuss FM
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():197-9. PubMed ID: 10444237
[TBL] [Abstract][Full Text] [Related]
12. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
13. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
Roy M; Dumaine R; Brown AM
Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
[TBL] [Abstract][Full Text] [Related]
14. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
15. The inconstancy of the human heart.
Miller C
Nature; 1996 Feb; 379(6568):767-8. PubMed ID: 8587597
[No Abstract] [Full Text] [Related]
16. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
17. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
[TBL] [Abstract][Full Text] [Related]
18. Biased agonism at histamine H
Burghi V; Echeverría EB; Zappia CD; Díaz Nebreda A; Ripoll S; Gómez N; Shayo C; Davio CA; Monczor F; Fernández NC
Eur J Pharmacol; 2021 Apr; 896():173913. PubMed ID: 33508282
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists.
Bakker RA; Wieland K; Timmerman H; Leurs R
Eur J Pharmacol; 2000 Jan; 387(1):R5-7. PubMed ID: 10633171
[TBL] [Abstract][Full Text] [Related]
20. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
